Skip to main content
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems
  • Log in
  • My alerts
  • My Cart

Main menu

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • COVID-19 Special Collection
    • Archive
    • Minireviews
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About JCM
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems

User menu

  • Log in
  • My alerts
  • My Cart

Search

  • Advanced search
Journal of Clinical Microbiology
publisher-logosite-logo

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • COVID-19 Special Collection
    • Archive
    • Minireviews
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About JCM
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
Letter to the Editor

Evaluation of the ResistancePlus MG FleXible Cartridge for Near-Point-of-Care Testing of Mycoplasma genitalium and Associated Macrolide Resistance Mutations

E. L. Sweeney, L. P. Mhango, S. Ebeyan, L. Y. Tan, C. Bletchly, G. R. Nimmo, D. M. Whiley
Erik Munson, Editor
E. L. Sweeney
aUniversity of Queensland Centre for Clinical Research (UQ-CCR), Faculty of Medicine, The University of Queensland, Brisbane, Queensland, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for E. L. Sweeney
L. P. Mhango
aUniversity of Queensland Centre for Clinical Research (UQ-CCR), Faculty of Medicine, The University of Queensland, Brisbane, Queensland, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
S. Ebeyan
bSpeeDx Pty Ltd., Sydney, New South Wales, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
L. Y. Tan
bSpeeDx Pty Ltd., Sydney, New South Wales, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
C. Bletchly
cPathology Queensland Central Laboratory, Queensland, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
G. R. Nimmo
cPathology Queensland Central Laboratory, Queensland, Australia
dGriffith University, School of Medicine, Queensland, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
D. M. Whiley
aUniversity of Queensland Centre for Clinical Research (UQ-CCR), Faculty of Medicine, The University of Queensland, Brisbane, Queensland, Australia
cPathology Queensland Central Laboratory, Queensland, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Erik Munson
Marquette University
Roles: Editor
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI: 10.1128/JCM.01897-19
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

LETTER

Mycoplasma genitalium is an important sexually transmitted infection that can cause acute and/or chronic urethritis in males and females, and its prevalence is approximately 16% in females and 17% in males (1). Globally, macrolide resistance is estimated to exceed 50% in most urban centers (1–6), and in our local region of Queensland, Australia, it exceeds 60% (7). PCR is routinely used for diagnosis of M. genitalium and macrolide resistance mutations at positions 2058 and 2059 of the 23S rRNA gene; however, the turnaround times of laboratory-based methods often exceed 24 h and so may not be sufficiently timely to inform clinical management for symptomatic patients. Here, we evaluated the performance of the ResistancePlus MG FleXible cartridge test on the Cepheid GeneXpert (hereafter termed MG-Flex), which offers the potential for near-point-of-care testing.

A bank of 181 clinical samples (M. genitalium positive, n = 63, and negative, n = 118) from 145 males and 36 females was used in this study. Original patient samples were stored at 4°C for 4 weeks, then at −20°C for longer-term storage. Nucleic acid samples were stored at −20°C until required. Full details of the samples are provided in Table S1 in the supplemental material. The samples had all been submitted for routine M. genitalium testing to Pathology Queensland (Brisbane, Australia) where they were tested using an in-house PCR that detects the MgPa gene of M. genitalium (hereafter termed in-house MgPa-PCR) (8). For the purposes of this evaluation, all samples were tested using the MG-Flex near-point-of-care assay (which detects the macrolide resistance mutations A2058T, A2058C, A2058G, and A2059G) as well as the SpeeDx ResistancePlus MG test (hereafter termed RPMG, which detects the macrolide resistance mutations A2058T, A2058C, A2058T, A2059C, and A2059G). The RPMG test is a Therapeutic Goods Administration (TGA, Australia) cleared and CE-IVD-marked (i.e., Conformité Européene-marked for in vitro diagnostic) laboratory-based test.

The MG-Flex assay was prepared per the kit instructions. Briefly, 44 μl of MG-Flex mastermix, 1 ml of neat (unextracted) clinical sample, and 10 μl of internal control were added to the FleXible cartridge (Cepheid). In some instances, swab specimens (n = 17; Table S1) had less than 1 ml of sample, so the volume was made up to 1 ml with sterile molecular-grade water. The RPMG assay was performed per the manufacturer’s instructions using stored DNA extracts from the routine testing in the in-house MgPa-PCR.

This study was approved by the Children’s Health Queensland human research ethics committee (HREC/12/QRCH/139).

The results are summarized in Table 1 and further detailed in Table S1. The MG-Flex assay detected M. genitalium in 61 of 63 known positive samples, providing a sensitivity of 96.8%. The two samples providing negative results by the MG-Flex assay (samples 62 and 63; Table S1) were both from males. For sample 62, a reduced starting volume of sample likely contributed to discordance, and in both samples, low M. genitalium load was observed. One hundred sixteen M. genitalium-negative samples were negative in the MG-Flex assay, while two samples provided invalid results (samples 180 and 181; Table S1), and there was insufficient sample to repeat testing. MG-Flex assay specificity for evaluable samples was therefore 100%. The detection of macrolide resistance mutations by the MG-Flex assay correlated 100% with that of the RPMG assay, with the exception of two samples providing negative results for M. genitalium in the MG-Flex assay (samples 62 and 63; Table S1). The overall agreement between the RPMG and MG-Flex assays was 98.9%, with a kappa value of 0.98. The detection limit was also assessed by testing 10-fold dilutions of an M. genitalium-positive sample, and the MG-Flex test was able to reliably detect an additional dilution over the RPMG assay (Table S1).

View this table:
  • View inline
  • View popup
  • Download powerpoint
TABLE 1

Summary of results of the RPMG and MG-Flex assaysa

In summary, we found that the MG-Flex cartridge test was highly sensitive and specific for the detection of M. genitalium and 23S rRNA mutations.

ACKNOWLEDGMENTS

We thank Pathology Queensland staff for their assistance with this study.

D.M.W. reports research funding from SpeeDx Pty Ltd. The RPMG and MG-Flex assays were provided by SpeeDx Pty Ltd. Co-authors from SpeeDx Pty Ltd. (S.E. and L.Y.T.) participated in the study conception and design, data analysis, and manuscript writing.

This work was supported by The University of Queensland strategic funding.

FOOTNOTES

    • Accepted manuscript posted online 2 January 2020.
  • Supplemental material is available online only.

  • Copyright © 2020 American Society for Microbiology.

All Rights Reserved.

REFERENCES

  1. 1.↵
    1. Getman D,
    2. Jiang A,
    3. O'Donnell M,
    4. Cohen S
    . 2016. Mycoplasma genitalium prevalence, coinfection, and macrolide antibiotic resistance frequency in a multicenter clinical study cohort in the United States. J Clin Microbiol 54:2278–2283. doi:10.1128/JCM.01053-16.
    OpenUrlAbstract/FREE Full Text
  2. 2.↵
    1. Dumke R,
    2. Thurmer A,
    3. Jacobs E
    . 2016. Emergence of Mycoplasma genitalium strains showing mutations associated with macrolide and fluoroquinolone resistance in the region Dresden, Germany. Diagn Microbiol Infect Dis 86:221–223. doi:10.1016/j.diagmicrobio.2016.07.005.
    OpenUrlCrossRef
  3. 3.↵
    1. Gesink D,
    2. Racey CS,
    3. Seah C,
    4. Zittermann S,
    5. Mitterni L,
    6. Juzkiw J,
    7. Jamieson H,
    8. Greer J,
    9. Singh S,
    10. Jensen JS,
    11. Allen V
    . 2016. Mycoplasma genitalium in Toronto, Ont: estimates of prevalence and macrolide resistance. Can Fam Physician 62:e96–e101.
    OpenUrlAbstract/FREE Full Text
  4. 4.↵
    1. Jensen JS,
    2. Bradshaw CS,
    3. Tabrizi SN,
    4. Fairley CK,
    5. Hamasuna R
    . 2008. Azithromycin treatment failure in Mycoplasma genitalium-positive patients with nongonococcal urethritis is associated with induced macrolide resistance. Clin Infect Dis 47:1546–1553. doi:10.1086/593188.
    OpenUrlCrossRefPubMedWeb of Science
  5. 5.↵
    1. Gratrix J,
    2. Plitt S,
    3. Turnbull L,
    4. Smyczek P,
    5. Brandley J,
    6. Scarrott R,
    7. Naidu P,
    8. Parker P,
    9. Blore B,
    10. Bull A,
    11. Shokoples S,
    12. Bertholet L,
    13. Martin I,
    14. Chernesky M,
    15. Read R,
    16. Singh A
    . 2017. Prevalence and antibiotic resistance of Mycoplasma genitalium among STI clinic attendees in Western Canada: a cross-sectional analysis. BMJ Open 7:e016300. doi:10.1136/bmjopen-2017-016300.
    OpenUrlAbstract/FREE Full Text
  6. 6.↵
    1. Deguchi T,
    2. Yasuda M,
    3. Horie K,
    4. Seike K,
    5. Kikuchi M,
    6. Mizutani K,
    7. Tsuchiya T,
    8. Yokoi S,
    9. Nakano M,
    10. Hoshina S
    . 2015. Drug resistance-associated mutations in Mycoplasma genitalium in female sex workers, Japan. Emerg Infect Dis 21:1062–1064. doi:10.3201/eid2106.142013.
    OpenUrlCrossRefPubMed
  7. 7.↵
    1. Sweeney EL,
    2. Trembizki E,
    3. Bletchly C,
    4. Bradshaw CS,
    5. Menon A,
    6. Francis F,
    7. Langton-Lockton J,
    8. Nimmo GR,
    9. Whiley DM,
    10. Sweeney EL,
    11. Trembizki E,
    12. Bletchly C,
    13. Bradshaw CS,
    14. Menon A,
    15. Francis F,
    16. Langton-Lockton J,
    17. Nimmo GR,
    18. Whiley DM
    . 2019. Levels of Mycoplasma genitalium antimicrobial resistance differ by both region and gender in the state of Queensland, Australia: implications for treatment guidelines. J Clin Microbiol 57. doi:10.1128/JCM.01555-18.
    OpenUrlCrossRef
  8. 8.↵
    1. Jensen JS,
    2. Bjornelius E,
    3. Dohn B,
    4. Lidbrink P
    . 2004. Use of TaqMan 5’ nuclease real-time PCR for quantitative detection of Mycoplasma genitalium DNA in males with and without urethritis who were attendees at a sexually transmitted disease clinic. J Clin Microbiol 42:683–692. doi:10.1128/jcm.42.2.683-692.2004.
    OpenUrlAbstract/FREE Full Text
PreviousNext
Back to top
Download PDF
Citation Tools
Evaluation of the ResistancePlus MG FleXible Cartridge for Near-Point-of-Care Testing of Mycoplasma genitalium and Associated Macrolide Resistance Mutations
E. L. Sweeney, L. P. Mhango, S. Ebeyan, L. Y. Tan, C. Bletchly, G. R. Nimmo, D. M. Whiley
Journal of Clinical Microbiology Feb 2020, 58 (3) e01897-19; DOI: 10.1128/JCM.01897-19

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Print

Alerts
Sign In to Email Alerts with your Email Address
Email

Thank you for sharing this Journal of Clinical Microbiology article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Evaluation of the ResistancePlus MG FleXible Cartridge for Near-Point-of-Care Testing of Mycoplasma genitalium and Associated Macrolide Resistance Mutations
(Your Name) has forwarded a page to you from Journal of Clinical Microbiology
(Your Name) thought you would be interested in this article in Journal of Clinical Microbiology.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Evaluation of the ResistancePlus MG FleXible Cartridge for Near-Point-of-Care Testing of Mycoplasma genitalium and Associated Macrolide Resistance Mutations
E. L. Sweeney, L. P. Mhango, S. Ebeyan, L. Y. Tan, C. Bletchly, G. R. Nimmo, D. M. Whiley
Journal of Clinical Microbiology Feb 2020, 58 (3) e01897-19; DOI: 10.1128/JCM.01897-19
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Top
  • Article
    • LETTER
    • ACKNOWLEDGMENTS
    • FOOTNOTES
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

KEYWORDS

Mycoplasma genitalium
SpeeDx
near point-of-care
macrolide
azithromycin
antimicrobial resistance

Related Articles

Cited By...

About

  • About JCM
  • Editor in Chief
  • Board of Editors
  • Editor Conflicts of Interest
  • For Reviewers
  • For the Media
  • For Librarians
  • For Advertisers
  • Alerts
  • RSS
  • FAQ
  • Permissions
  • Journal Announcements

Authors

  • ASM Author Center
  • Submit a Manuscript
  • Article Types
  • Resources for Clinical Microbiologists
  • Ethics
  • Contact Us

Follow #JClinMicro

@ASMicrobiology

       

ASM Journals

ASM journals are the most prominent publications in the field, delivering up-to-date and authoritative coverage of both basic and clinical microbiology.

About ASM | Contact Us | Press Room

 

ASM is a member of

Scientific Society Publisher Alliance

 

American Society for Microbiology
1752 N St. NW
Washington, DC 20036
Phone: (202) 737-3600

 

Copyright © 2021 American Society for Microbiology | Privacy Policy | Website feedback

Print ISSN: 0095-1137; Online ISSN: 1098-660X